Business
Earth Science Tech, Inc. Shares Updates on its CBD Formula Patents and Medical Device Progress
Earth Science Tech, Inc. Shares Updates on its CBD Formula Patents and Medical Device Progress.
About this update from Earth Science Tech, Inc.
[{"type":"text","content":"\nDORAL, Florida, June 07, 2018 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST\" or the “Company\"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, as well as research and development, is pleased to share updates on its ongoing CBD formula patents and medical device progress.\n In March 2018 the Company announced it had received a grant from the Government of Quebec to develop its three new cannabinoid-based products. The prototyping of the three CBD formula patents has begun at CDBQ. The first batch will be tested by the team, and in vitro testing will begin in summer 2019 to show the superior antioxidant activities and better anti-proliferative effects on breast cancer cells. The stability tests will be done over a 1-year period. The third product, which is a superfood edible, will be ready for Q4 of 2018. The branding of these unique products is currently in the planning stage. It is anticipated that these original products, made from high quality ingredients, will achieve great success since their function is to maintain quality of life, prevent inflammation, cancer and degenerative diseases. Earth Science Tech also shares its progress in the launch of the MSN-2 medical device and finalization of the last step before large scale deployment. The company is working with Accélération, Design et Innovation Inc. (ADI Hardware Accelerator). The final packaging will have a great look that women – the target market - will appreciate. Our partners from Djibouti, Morocco, Vietnam, and the Middle East can’t wait to see and test our new medical device which is dedicated to improving the health of women in their countries and around the world. The Company’s CEO and Chief Science Officer, Dr. Michel Aubé stated, “The official launch of this medical device is a little like giving birth. It will be unique in the marketplace and we are branding this device globally. The commercial name will be announced soon, as we are in the process of trademark protection for the logo and name. We will create a strong demand for this medical device by showing the world its powerful capacity to diminish the prevalence of chlamydia and other Sexually Transmitted Infections.” About Earth Science Tech, Inc. (ETST)...